Table 1 Patients' clinical features according to the study groups
Variables | Study cohort (n = 131) Mean ± SD or Median (Min–Max) or N(%) | LVMR (n = 51) Mean ± SD or Median (Min–Max) or N(%) | TPMR (n = 80) Mean ± SD or Median (Min–Max) or N(%) | p-value* |
|---|---|---|---|---|
Age | 50.35 ± 13.51 (24–87) | 48.63 ± 11.41 | 51.45 ± 14.66 | 0.25 |
ASA | ||||
I | 83 (63.35) | 34 (66.66) | 49 (61.25) | 0.67 |
II | 44 (33.58) | 15 (29.41) | 29 (36.25) | |
III | 4 (3.05) | 2 (3.92) | 2 (2.5) | |
BMI (kg/m2) | 24.96 ± 4.78 (18–40) | 23.58 ± 4.57 | 25.85 ± 4.72 | 0.21 |
Parity | 2 (0–10) | 2 (0–4) | 2 (0–10) | 0.09 |
Operative time (minutes) | 111.98 ± 42.77 (40–200) | 151.37 ± 31.54 | 86.87 ± 27.21 | 0.000 |
Operative bleeding (ml) | 6.62 ± 2.97 (3–20) | 5.41 ± 2.06 | 7.40 ± 3.20 | 0.006 |
Clavien-Dindo | ||||
I | 3 (2.29) | 3 (3.75) | 0.045 | |
II | 2 (1.52) | - | 2 (2.5) | |
III | 1 (0.76) | 1 (1.25) | ||
Mean LOS (days) | 1.10 ± 0.37 (1–4) | 1.07 ± 0.27 | 1.12 ± 0.43 | 0.71 |
Mean Follow-up (months) | 35.43 ± 17.09 (12–80) | 29.01 ± 11.04 | 39.52 ± 18.97 | 0.21 |
Recurrence | 3 (2.29) | 2 (3.92) | 1 (1.25) | 0.31 |